All Stories

  1. Vitamin D in coronary heart disease: a Mendelian randomization meta-analysis of data stratified by 25(OH)D levels
  2. Prevalence of Fabry disease GLA  variants among patients with parapelvic cysts: a Multicenter Italian Cohort Study
  3. Prevalence and burden of chronic kidney disease-associated pruritus in Europe (CENSUS-EU)
  4. Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care
  5. Interventions for treating COVID-19 in people with chronic kidney disease
  6. Multifetal Pregnancies in Women with CKD
  7. A Consensus Statement on the management of Vertebral Fractures in CKD stages G4-G5D
  8. Effectiveness of Mycophenolate Mofetil Trough Level Monitoring in Children with Relapsing Nephrotic Syndrome
  9. Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists
  10. Addressing the inequity of access to home Dialysis in Europe: recommendations for action informed by an international consensus exercise
  11. Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?
  12. Building Interventional Nephrology Skills in India: A Decade-Long Journey by the AVATAR Foundation
  13. Dietary Phosphorus and Metabolic Health in CKD and ESKD
  14. Calcitriol supplementation after kidney transplantation: results of a double-blinded, randomized, placebo-controlled trial
  15. Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs
  16. Leadless pacemakers in patients with different stages of chronic kidney disease: Real-world data from the updated i-LEAPER registry
  17. Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study
  18. Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology
  19. Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity—An Italian Study
  20. Vitamin D assay and supplementation: still debatable issues
  21. Rationale and Design of PURE: A Randomized Controlled Trial to Evaluate Peritoneal Ultrafiltration with PolyCore™ in Refractory Congestive Heart Failure
  22. Post-Kidney Transplant Cancer: A Real-World Retrospective Analysis From a Single Italian Center
  23. Rationale and Protocol of ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity Italian Study
  24. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) Erasmus+ project: The Renal Expert in Vascular Access (REVAC) module
  25. Vitamin D Assay and Supplementation: Still Debatable Issues
  26. How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists
  27. Variation in performing kidney biopsy amongst nephrologists in the Asia-Pacific region: A multinational survey
  28. Vascular access for hemodialysis in Italy: What a national survey reveals
  29. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers’ perspective
  30. Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices
  31. Assisted PD throughout Europe: advantages, inequities, and solution proposals
  32. Practice of dialysis access interventional nephrology procedures in the Asia‐Pacific region: Getting lay of the land
  33. Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study
  34. Vascular access hands-on training for young nephrologists: The fellows’ experience of the N-PATH project REVAC module
  35. High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: Commentary
  36. Post-mortem renal histopathological findings in 43 COVID-19 patients with acute kidney injury (AKI) deceased in the intensive care unit
  37. A decision-making algorithm proposal for PICCs and midlines insertion in patients with advanced kidney disease: A pilot study
  38. Magnetic Resonance Visibility, Artifacts, and Overall Safety of the Self-Locating Peritoneal Dialysis Catheter with a Tungsten Tip
  39. Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study
  40. α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response
  41. Pathophysiology of AV Fistula Maturation and Non-Maturation
  42. Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings
  43. Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus
  44. The multispeciality approach to the management of localised kidney cancer
  45. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes
  46. Availability of assisted peritoneal dialysis in Europe: call for increased and equal access
  47. Influence of peritoneal dialysis catheter type on dislocations and laxative use: a retrospective observational study
  48. Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
  49. One year of Hybrid Closed Loop on peritoneal dialysis: a case report
  50. Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document
  51. Peritoneal Dialysis for Potential Kidney Transplant Recipients: Pride or Prejudice?
  52. The Role of Vitamin K in CKD-MBD
  53. The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study
  54. Bone Biopsy for Histomorphometry in Chronic Kidney Disease (CKD): State-of-the-Art and New Perspectives
  55. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease
  56. Ultrasound in central venous access for hemodialysis
  57. Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP)
  58. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study
  59. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
  60. Renin-Angiotensin System Blockers and the Risk of COVID-19–Related Mortality in Patients with Kidney Failure
  61. Impact of National Economy and Policies on End-Stage Kidney Care in South Asia and Southeast Asia
  62. Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia
  63. How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
  64. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis
  65. Current Status and Future of End-Stage Kidney Disease in Gulf Cooperation Council Countries: Challenges and Opportunities
  66. Targeting COVID-19 prevention in hemodialysis facilities is associated with a drastic reduction in central venous catheter-related infections
  67. Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study
  68. Preventive strategies for acute kidney injury in cancer patients
  69. Vitamin K and Osteoporosis
  70. Medical Nutritional Therapy for Patients with Chronic Kidney Disease not on Dialysis: The Low Protein Diet as a Medication
  71. Hemodialysis vascular access affects heart function and outcomes: Tips for choosing the right access for the individual patient
  72. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
  73. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
  74. Multicenter Experience with the Surfacer Inside-Out Access Catheter System in Patients with Thoracic Venous Obstruction: Results from the SAVE Registry
  75. Vitamin K and Kidney Transplantation
  76. Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction
  77. Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis
  78. Plant-based kidney diets prescribed in nutrition clinics: clinical advantages with low risks of hyperkalemia
  79. Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients
  80. Delivering Safe and Effective Hemodialysis in Patients with Suspected or Confirmed COVID-19 Infection: A Single-Center Perspective from Italy
  81. Clinical relevance of the left brachiocephalic vein anatomy for vascular access in dialysis patients
  82. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease
  83. Vitamin K effects in human health: new insights beyond bone and cardiovascular health
  84. Phosphate and bone fracture risk in chronic kidney disease patients
  85. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
  86. Dietary Fiber and Gut Microbiota in Renal Diets
  87. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine
  88. Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients
  89. Endorsement and evaluation of dialysis access guidelines from the standpoint of the Vascular Access Society
  90. Update on ANCA-associated vasculitis: from biomarkers to therapy
  91. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
  92. Dietary Fiber and Gut Microbiota in Renal Diets
  93. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults
  94. Quality assessment of vascular access procedures for hemodialysis: A position paper of the Vascular Access Society based on the analysis of existing guidelines
  95. The adjuvant treatment of kidney cancer: a multidisciplinary outlook
  96. Antiplatelet therapy for prevention of hemodialysis vascular access thrombosis and improving survival
  97. Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus
  98. A Virtual Reality Environment to Visualize Three-Dimensional Patient-Specific Models by a Mobile Head-Mounted Display
  99. Utility of Cardiac Biomarkers in the Setting of Kidney Disease
  100. Patients’ wishes, pregnancy and vascular access: When one size does not fit all
  101. Extracorporeal Removal of Light Chains
  102. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines
  103. Cigarette Smoking is Associated with Decreased Bone Gla-protein (BGP) Levels in Hemodialysis Patients
  104. Materials and techniques for percutaneous retrieval of intravascular foreign bodies
  105. Urinary Phosphorus Excretion
  106. Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
  107. Clinical relevance and future perspective of fractures in patients with chronic kidney disease
  108. Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access
  109. Authors’ Response to Comments on: The DRIL Procedure for Arteriovenous Access Ischemic Steal: A Controversial Approach
  110. Urinary N-acetyl-β -glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy
  111. Surgical and Endovascular Intervention for Dialysis Access Maturation Failure During and After Arteriovenous Fistula Surgery: Review of the Evidence
  112. Response to: The role of interventional radiology in detecting abnormalities of the superior vena cava anatomy
  113. Acute Kidney Injury in Cancer Patients
  114. OUP accepted manuscript
  115. Response to: The Role of Ultrasound Evaluation in Central Venous Catheter Exchange
  116. Lupus nephritis and B-cell targeting therapy
  117. Vitamin K plasma levels determination in human health
  118. Erratum to: The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology
  119. Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake
  120. Low vitamin K1 intake in haemodialysis patients
  121. Dialysis access: issues related to conversion from peritoneal dialysis to hemodialysis and vice versa
  122. Response to: Central venous catheterization in fragile patients: which is the best approach?
  123. A Survival Benefit With Phosphate-Binder Treatment in CKD Patients Cannot Be Excluded
  124. Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
  125. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
  126. microscopic hematuria in clinical practice, diagnosis at the point of care
  127. Sudden Death in End Stage Renal Disease: Comparing Hemodialysis versus Peritoneal Dialysis
  128. Vitamin K and bone
  129. DASH and Mediterranean Diets as Nutritional Interventions for CKD Patients
  130. Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up
  131. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study
  132. Poor early growth and high salt intake in Indian infants
  133. Management of Hyperphosphatemia
  134. The role of monocytes in ANCA-associated vasculitides
  135. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology
  136. The DRIL procedure for arteriovenous access ischemic steal: a controversial approach
  137. FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease
  138. Echo Color Doppler Ultrasound: A Valuable Diagnostic Tool in the Assessment of Arteriovenous Fistula in Hemodialysis Patients
  139. Haemodialysis Plastic Cannulae - a Possible Alternative to Traditional Metal Needles?
  140. Harmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug Development
  141. Medicaid Coverage and Access to Care for American Indians and Alaska Natives Under the Affordable Care Act
  142. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease
  143. Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs)
  144. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study
  145. Optimization of Dialysis Catheter Function
  146. Training in Dialysis Access - Charting Future Success
  147. The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology
  148. Diagnostic and prognostic role of myocardial perfusion scintigraphy in kidney transplant candidates: narrative review
  149. Transplantation of kidneys with tumors
  150. Glomerular diseases and cancer: evaluation of underlying malignancy
  151. Grundlagen der Peritonealdialyse
  152. Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients
  153. Appropriatezza della farmacoterapia nel paziente anziano nefropatico
  154. Renal toxicity of anticancer agents targeting HER2 and EGFR
  155. Onco-nephrology: a decalogue: Table 1.
  156. Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function
  157. Renal cancer in kidney transplanted patients
  158. Setting Priorities for Optimizing Vascular Access Decision Making – An International Survey of Patients and Clinicians
  159. Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins
  160. Aneurysms and pseudoaneurysms in dialysis access
  161. Erratum to: Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study
  162. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study
  163. Prevalence of Vertebral Fractures, Vascular Calcifications, and Mortality in Warfarin Treated Hemodialysis Patients
  164. Mortality, sudden death and indication for cardioverter defibrillator implantation in a dialysis population
  165. Tunneled Central Venous Catheter Exchange: Techniques to Improve Prevention of Air Embolism
  166. Renal effects of targeted anticancer therapies
  167. Retro-aortic, left inferior renal capsular vein
  168. Type of peritoneal dialysis catheter and outcomes
  169. Preferred haemodialysis vascular access for diabetic chronic kidney disease patients: a systematic literature review
  170. Congenital anomalies of superior vena cava and their implications in central venous catheterization
  171. Optimizing vascular access in the elderly: words we use affect patient care
  172. Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation
  173. Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon?
  174. Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?
  175. Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications
  176. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness
  177. Evaluation of renal function in elderly patients
  178. The nephrologist’s anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation
  179. The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients
  180. Dialysis central venous catheter types and performance
  181. Fractures in chronic kidney disease: neglected, common, and associated with sickness and death
  182. The Burden of Hypertension and Kidney Disease in Northeast India: The Institute for Indian Mother and Child Noncommunicable Diseases Project
  183. Training and certification in dialysis access
  184. Which cannulation technique for which patient
  185. Reprint of: Vitamin D receptor activation and prevention of arterial ageing
  186. Hypertension and kidney function in an adult population of West Bengal, India: Role of body weight, waist circumference, proteinuria and rural area living
  187. Peritoneal Ultrafiltration in Refractory Heart Failure: A Cohort Study
  188. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
  189. Percutaneous ultrasound-guided central venous catheters: the lateral in-plane technique for internal jugular vein access
  190. Phosphate control in dialysis
  191. Left ventricular hypertrophy and serum phosphate in peritoneal dialysis patients
  192. Lethal pulmonary thromboembolism: An autopsy-based study on a rare but legally relevant event
  193. Angiotensin II, distal nephron acidification, acid retention, and possibly increased ammonia levels?
  194. Long-Term Proton Pump Inhibitor Use is Associated with Vascular Calcification in Chronic Kidney Disease: A Cross-Sectional Study Using Propensity Score Analysis
  195. High Prevalence of Vertebral Fractures Assessed by Quantitative Morphometry in Hemodialysis Patients, Strongly Associated with Vascular Calcifications
  196. Vitamin K and bone metabolism in the elderly with normal and reduced kidney function
  197. Inequalities in Transplant Waiting List Activation across Italian Dialysis Centers
  198. Peritoneal dialysis access: open versus laparoscopic surgical techniques
  199. Urinary IgG andα2-Macroglobulin Are Powerful Predictors of Outcome and Responsiveness to Steroids and Cyclophosphamide in Idiopathic Focal Segmental Glomerulosclerosis with Nephrotic Syndrome
  200. Prevention of catheter-related blood stream infections (CRBSI)
  201. Virtual Reality: Emerging Role of Simulation Training in Vascular Access
  202. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study
  203. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study
  204. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care
  205. Consequences of Vitamin K2 Deficiency in Hemodialysis Patients
  206. Vitamin D receptor activation and prevention of arterial ageing
  207. Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective
  208. Indications for vascular grafts as hemodialysis access: consensus from experience in Italy
  209. Phosphate Control in Peritoneal Dialysis
  210. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy
  211. Neurological complications of hemodialysis: state of the art
  212. Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies
  213. Sex and Gender Differences in Nephrology
  214. Clinical signifi cance of FGF-23 measurement in dialysis patients
  215. GLOMERULAR MEMBRANOUS NEPHROPATHY AND WERNER SYNDROME: A CASE REPORT
  216. Effects of vitamin K intake on gamma-carboxylated proteins, bone fractures, and vascular calcifications
  217. Treatment with Calcimimetic (Cinacalcet) Alters Epoetin Dosage Requirements in Dialysis Patients: Preliminary Report
  218. High prevalence of hypertension in normal and underweight Indian children
  219. A Complex Renal Cyst: It Is Time to Call the Oncologist?
  220. Central venous catheters: legal issues
  221. Developing recommendations for vascular access for hemodialysis: Vascular Access Working Group of the Italian Society of Nephrology
  222. Does Systematic Preliminar Colour Doppler Study Reduce Kidney Biopsy Complication Incidence?
  223. Regimen Complexity and Prescription Adherence in Dialysis Patients
  224. Vitamin D Receptor Activators and Clinical Outcomes in Chronic Kidney Disease
  225. La calcificazione vascolare nel paziente con insufficienza renale cronica
  226. Plasma Anti-Xa Monitoring for Low-Molecular-Weight Heparins in Patients with Chronic Kidney Disease
  227. Warfarin and heterotopic ossification: good, bad or ugly?
  228. High-Dose Oral Vitamin D Supplementation and Risk of Falls in Older Women
  229. Diagnosis of acute pyelonephritis by contrast-enhanced ultrasonography in kidney transplant patients
  230. Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy: a case report
  231. Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis
  232. Effetti sulla funzione renale dei trattamenti antipertensivi associati
  233. CCN2 (CTGF) Gene Polymorphism Is a Novel Prognostic Risk Factor for Cardiovascular Outcomes in Hemodialysis Patients
  234. Vascular Calcification and Cardiovascular Outcome in Dialysis Patients: The Role of Gene Polymorphisms
  235. Doppler ultrasound and renal artery stenosis: An overview
  236. Arterial Accelerated Aging in Dialysis Patients: The Clinical Impact of Vascular Calcification
  237. Dialysis Access in Europe and North America: Are We on the Same Path?
  238. Management of Secondary Hyperparathyroidism in the Elderly Patient with Chronic Kidney Disease
  239. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients
  240. Inflammation and vascular calcification in chronic kidney disease: The role of Fetuin-A
  241. Importance of Vitamin D Receptor Activation in Clinical Practice
  242. New Acquisitions in Therapy of Secondary Hyperparathyroidism in Chronic Kidney Disease and Peritoneal Dialysis Patients: Role of Vitamin D Receptor Activators
  243. Substitution of Calcium Carbonate for Aluminum Hydroxide in Patients on Hemodialysis
  244. Renal outcomes in the ONTARGET study
  245. Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients
  246. Vascular Access in Oncology Patients
  247. Vertebral fractures in patients on dialysis: a clinically relevant problem with insufficient investigation
  248. Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease
  249. Calcium and phosphate: serum levels versus body balance
  250. Pathogenesis and Treatment of Secondary Hyperparathyroidism in Dialysis Patients: The Role of Paricalcitol
  251. Successful use of low-dose intravenous paricalcitol in the treatment of severe secondary hyperparathyroidism in a haemodialysis patient
  252. Preventive Measures and New Pharmacological Approaches of Calcium and Phosphate Disorders
  253. Clinical policies on the management of chronic kidney disease patients in Italy
  254. Machiavelli and urinalysis
  255. Gene Polymorphisms and Serum Alpha-2-Heremans-Schmid Levels in Italian Haemodialysis Patients
  256. Serum Fetuin-A Levels Link Inflammation and Cardiovascular Calcification in Hemodialysis Patients
  257. Decreased serum fetuin-A levels after a single haemodialysis session
  258. Phosphate overload accelerates vascular aging in uremic patients
  259. Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients
  260. Calcium and Phosphate Handling in Peritoneal Dialysis
  261. Vascular Calcification in Uremic Conditions: New Insights into Pathogenesis
  262. Matrix GLA Protein Gene Polymorphisms: Clinical Correlates and Cardiovascular Mortality in Chronic Kidney Disease Patients
  263. Pathogenesis of vascular calcification in chronic kidney disease
  264. Work Ability and Health Status in Dialysis Patients
  265. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient
  266. Hyperparathyroidism and Anemia in Uremic Subjects: A Combined Therapeutic Approach
  267. Severe Cortical and Trabecular Osteopenia in Secondary Hyperparathyroidism
  268. Calcium and Phosphate Plasma Levels in Dialysis Patients after Dietary Ca-P Overload
  269. Captopril-Augmented Renal Scanning
  270. Aspiration Pneumonia
  271. Dynamic of β 2 ‐Microglobulin Fibril Formation and Reabsorption: The Role of Proteolysis
  272. Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder
  273. Hyperparathyroidism and Anemia in Renal Failure
  274.  -Interferon-Induced Resistance to 1,25-(OH)2 D3 in Human Monocytes and Macrophages: A Mechanism for the Hypercalcemia of Various Granulomatoses
  275. Trace elements in renal failure: are they clinically important?
  276. Treatment of hyperparathyroidism—why is it crucial to control serum phosphate?
  277. Microtubules Mediate Cellular 25-Hydroxyvitamin D3 Trafficking and the Genomic Response to 1,25-Dihydroxyvitamin D3 in Normal Human Monocytes
  278. Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects
  279. Recent advances in intravenous calcitriol treatment
  280. Differential catabolism of 22-oxacalcitriol and 1,25-dihydroxyvitamin D3 by normal human peripheral monocytes.
  281. Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
  282. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia
  283. OVERT DIALYSIS ENCEPHALOPATHY AND MILDLY RAISED PLASMA ALUMINIUM
  284. DIALYSIS AMYLOIDOSIS WITH MASSIVE POPLITEAL DEPOSITION OF β2-MICROGLOBULIN AMYLOID
  285. Aluminum-Dependent Transfusions in Dialysis
  286. What Every Doctor Should Know about Drug Safety in Patients with Chronic Kidney Disease